U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,732 records

Showing results for "secondary".

  1. Consequences of Medical Overuse | PSNet

    psnet.ahrq.gov/web-mm/consequences-medical-overuse
    May 05, 2021 - represented further overdiagnosis, and she may have received a stent and been started on more medications for secondary

  2. Hypoxemia after Emergency Intubation | PSNet

    psnet.ahrq.gov/web-mm/hypoxemia-after-emergency-intubation
    March 24, 2019 - High flow oxygen therapy in respiratory failure secondary to drowning.

  3. Sources of KID Data and State-Specific Restrictions 2003

    hcup-us.ahrq.gov/db/nation/kid/kid_2003_stspecific_restr.jsp
    January 01, 2000 - The HIV or drug/alcohol use patients are identified by any principal or secondary diagnosis code on the

  4. Don't Dismiss the Dangerous: Obstetric Hemorrhage | PSNet

    psnet.ahrq.gov/web-mm/dont-dismiss-dangerous-obstetric-hemorrhage
    August 21, 2024 - If bleeding is recognized, the standard next steps include administering secondary medications like methergine

  5. Cognitive Overload in the ICU | PSNet

    psnet.ahrq.gov/web-mm/cognitive-overload-icu
    June 01, 2005 - year-old woman was admitted to the intensive care unit (ICU) with acute respiratory distress syndrome secondary

  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/866826/psn-pdf
    September 25, 2024 - Should pipeline nitrous oxide be discontinued in secondary care: a cost-benefit analysis.

  7. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49431/psn-pdf
    January 01, 2004 - common, because symptoms will vary depending on the exact anatomic location of the dissection and the secondary

  8. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49721/psn-pdf
    December 01, 2014 - Otherwise, the specimen can be transported in a biohazard bag within a durable, leak-proof secondary

  9. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33793/psn-pdf
    November 01, 2015 - So I recommend some combination of finding the right secondary source—in this case PSNet—and following

  10. Delirium or Dementia? | PSNet

    psnet.ahrq.gov/web-mm/delirium-or-dementia
    September 27, 2023 - Am I restraining the patient for secondary benefits (to limit phone calls/pages, to assuage nursing requests

  11. CA-MRSA Skin Infections: An Ounce of Prevention is Worth a Pound of Cure | PSNet

    psnet.ahrq.gov/web-mm/ca-mrsa-skin-infections-ounce-prevention-worth-pound-cure
    March 01, 2005 - A radiograph showed extensive erosion at the femur head secondary to osteomyelitis.

  12. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
    May 01, 2017 - primary OA of the knee is the result of the progressive joint cartilage destruction over time, whereas secondary … chondroitin, and arthroscopic surgery (the title of the original review, “Treatment of Primary and Secondary … Treatment of primary and secondary osteoarthritis of the knee. … Physical Therapy Interventions for Knee Pain Secondary to Osteoarthritis. … Physical Therapy Interventions for Knee Pain Secondary to Osteoarthritis.

  13. Patient-Monitoring-Systems-Appendix-C (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
    January 01, 2024 - Primary outcomes • Hospital mortality Secondary outcomes • Composite outcome (unexpected cardiac arrests … Secondary outcomes in the meta-analysis included inhospital mortality and hospital length of stay. … Further secondary patient outcomes were reported in the narrative analysis, such as 30-day readmission … ofmaximumEDI score since admission Gallo, 2024 Arm 1 -Usual care/In person Maximum EDI <65 Rates of the secondary … Index, and timing ofmaximumEDI score since admission Gallo, 2024 Arm 2 Maximum EDI ≥65 Rates of the secondary

  14. HEALTHCARE COST AND UTILIZATION PROJECT — HCUP (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2019.pdf
    September 01, 2021 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information ICD-10-CM diagnoses I10_DX1 – I10_DX40 ICD-10-CM diagnoses, principal and secondary … Coding Notes ICD-10-PCS procedures I10_PR1 – I10_PR25 ICD-10-PCS procedures, principal and secondary … of days from admission to principal procedure PRDAY2 – PRDAY25 Number of days from admission to secondary

  15. Nrd 2014 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core_Weighted.PDF
    January 01, 2014 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,786 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 12,627 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 95,177 … 0.27% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 5,298 0.02% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 18,439 0.05% 41: Cancer; other and unspecified primary 7,459 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  16. Nrd 2013 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core.PDF
    January 01, 2013 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 843 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 4,762 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 40,324 … 0.28% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 2,812 0.02% 849: RADIOTHERAPY … 0.12% 40: Multiple myeloma 8,257 0.06% 41: Cancer; other and unspecified primary 2,948 0.02% 42: Secondary … disease) 30,185 0.21% 98: Essential hypertension 26,413 0.18% 99: Hypertension with complications and secondary

  17. Nrd 2013 Maskedstats Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core_Weighted.PDF
    January 01, 2013 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,941 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 11,070 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 98,666 … 0.28% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 6,678 0.02% please … 0.11% 40: Multiple myeloma 19,485 0.05% 41: Cancer; other and unspecified primary 7,609 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  18. Nrd 2012 Maskedstats Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2.PDF
    January 01, 2012 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 837 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 4,005 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 38,654 … 0.29% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 2,936 0.02% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 7,936 0.06% 41: Cancer; other and unspecified primary 2,917 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  19. Nrd 2012 Maskedstats Core V2 Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2012 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 2,236 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 9,808 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 99,474 … 0.27% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 7,617 0.02% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 19,996 0.05% 41: Cancer; other and unspecified primary 7,786 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

  20. Nrd 2011 Maskedstats Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2.PDF
    January 01, 2011 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 915 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 3,803 0.03% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 40,530 … 0.29% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 3,395 0.02% 849: RADIOTHERAPY … 0.11% 40: Multiple myeloma 7,796 0.06% 41: Cancer; other and unspecified primary 3,033 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1196)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (695)

digital.ahrq.gov (428)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (16)

integrationacademy.ahrq.gov (8)

meps.ahrq.gov (7)

datatools.ahrq.gov (4)

qualityindicators.ahrq.gov (4)

pso.ahrq.gov (2)